Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 235 (LINC00235) is a human long non-coding RNA gene located on chromosome 16. It is classified as a lincRNA, which means it is transcribed from a region of the genome that does not overlap protein-coding genes, and it does not appear to code for any protein. Its sequence and structure are predicted, and as of now, its specific biological function or disease implication has not been established. LincRNAs as a class have been shown to play diverse roles in regulating gene expression and chromatin organization, but LINC00235 itself remains functionally uncharacterized. It is not considered a conventional pharmacological target such as a receptor, enzyme, or transporter, and there are no drugs or specific clinical biomarkers currently associated with it.
Not applicable; no drugs known to target LINC00235
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 235 (LINC00235).